Lipton RB, Goadsby PJ, Dodick DW, McGinley JS, et al. Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention. Headache 2022 Apr 25. doi: 10.1111/head.14295.
PMID: 35466430